Related Experiment Videos
Pharmaceutical marketing: implications for medical residency training
1Department of Family Practice, Carolinas Medical Center, Charlotte, NC 28232-2861, USA.
Pharmacotherapy
|January 1, 1996
Summary
This study created an educational program to help family practice residents better understand information from pharmaceutical representatives. Residents showed significant confidence improvement in handling drug details and analyzing promotional materials after the training.
Area of Science:
- Medical Education
- Pharmaceutical Marketing
- Family Medicine
Background:
- Pharmaceutical representatives are a key source of drug information for physicians.
- Effective communication and critical appraisal skills are essential for physicians interacting with industry representatives.
- Existing training gaps may hinder residents' ability to optimally utilize information from pharmaceutical detailing.
Purpose of the Study:
- To develop and evaluate an educational intervention for family practice residents.
- To enhance residents' skills in managing interactions with pharmaceutical representatives.
- To improve critical analysis of drug promotional materials and understanding of ethical considerations.
Main Methods:
- A curriculum based on one-on-one drug details was designed.
- The intervention included an assessment tool, readings, and structured interview questions.
- The program focused on interview control, critical analysis, and ethical discussions.
Main Results:
- Residents' confidence in managing interactions with pharmaceutical representatives improved significantly across all assessed areas.
- The intervention demonstrated positive effects on residents' self-perceived abilities.
- Long-term confidence gains were observed after a 5-year follow-up.
Conclusions:
- The educational intervention effectively enhanced family practice residents' confidence and skills.
- Training in drug detailing and critical appraisal is valuable for physicians.
- This approach can improve the quality of information physicians receive from the pharmaceutical industry.